Photo from Anand Patel/X
Jul 2, 2024, 13:10
Anand Patel: Does JAK2 VAF reduction in PV/ET impact outcomes in rux-treated patients?
Anand Patel, Assistant Professor and Director of the Inpatient Leukemia Service at the University of Chicago, shared on X/Twitter:
“Does JAK2 VAF reduction in PV/ET impact outcomes in rux-treated patients?
Pic 1 – MF-free survival in patients treated with rux on PV or ET trials:
Pic 2 – events on MAJIC-PV trial.”
Source: Anand Patel/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Feb 22, 2025, 16:16
Feb 22, 2025, 16:04
Feb 22, 2025, 16:00
Feb 22, 2025, 15:54
Feb 22, 2025, 15:48
Feb 22, 2025, 15:33
Feb 22, 2025, 15:14
Feb 22, 2025, 15:04
Feb 22, 2025, 14:43
Feb 22, 2025, 14:10
Feb 22, 2025, 13:28
Feb 22, 2025, 13:10